Trametinib

Vascular anomalies refer to a group of conditions where blood or lymphatic vessels develop abnormally. These include venous, lymphatic and combined malformations. Some vascular anomalies may cause pain, swelling, bleeding, or problems with movement and daily activities.

• What is trametinib?
  Trametinib helps control how cells grow. Some vascular anomalies are caused by changes in genes in the MAPK pathway that causes abnormal growth of the affected cells and trametinib is used to block this pathway.
  
  • Arteriovenous malformations (AVMs): These have abnormal connections between arteries and veins leading to swelling, pain, bleeding, or changes in appearance. Trametinib has shown benefit in early-stage and severe AVMs, especially when caused by changes in genes like KRAS, MAP2K1, or RASA1.
  • Complex lymphatic anomalies in Noonan syndrome and related disorders: Some people with Noonan syndrome or similar conditions have serious lymphatic problems (e.g. chylothorax or swelling) from changes in the RAS/MAPK pathway. Trametinib may help improve symptoms in these cases.
     
• What screening and monitoring blood tests are needed before starting trametinib?
  Before starting trametinib, doctors will check the following:
  
  • Full blood counts (FBC): To look for low white blood cells, red blood cells, or platelets.
  • Liver function tests: To make sure your liver is healthy enough for treatment.
  • Kidney function tests: To ensure the kidneys are working.
  • Blood pressure: Trametinib can cause high blood pressure. This needs to be checked regularly.
  • Heart function (Echocardiogram or MUGA scan): Trametinib can affect the heart’s pumping ability. Your doctor will check your heart function before starting, and then regularly during treatment.
  • Eye exam: If there are any changes to your vision, an eye exam may be required, as trametinib can rarely cause eye problems.
     
• How do you take trametinib?
  
  • For adults, the usual dose is 2mg by mouth once daily.
  • For children, the dose is weight dependent. In infants, much lower doses may be used, especially for lymphatic problems.
  • The medicine comes as a tablet or a liquid. It should be taken at the same time each day, with or without food.
     
• What are the benefits?
  Trametinib can help shrink AVMs, reduce pain, improve skin colour, and decrease blood flow through the abnormal vessels. In lymphatic problems, it can help reduce swelling and fluid build-up.
  
  
• How long does it take to see results?
  Most patients start to see improvement in symptoms or imaging findings within 3 to 6 months of commencing trametinib. In clinical studies of AVMs, significant changes in blood flow, skin colour, and lesion size were often observed by 6 months, with further improvement possible up to 12 months.
  
  
• What side effects should you watch for?
  The most common side effects are acne-like skin rash, nausea, diarrhoea, and swelling. Other possible side effects include mouth sores, high blood pressure, bleeding, and changes to heart function.
  Rarely, trametinib can cause serious skin reactions, vision changes, or lung problems. Sometimes the dose needs to be lowered or stopped.
  If you notice new symptoms like trouble breathing, chest pain, visual changes, or severe skin rashes, contact your doctor immediately.
  
  
• Other treatment options:
  Treatment for vascular anomalies may also include observation, sclerotherapy, embolisation or surgery. Trametinib or other targeted therapies are often considered when these options are not sufficient or not possible.
  
  
• Summary:
  Trametinib is a targeted treatment for vascular anomalies, in particular AVMs and complex lymphatic problems associated with gene changes in the MAPK pathway. It can alleviate symptoms and improve the quality of life, but it’s important to monitor for side effects and keep up with regular doctor appointments and tests.

The information above is also available for download in pdf format.